HLA class I antigens expression in renal cell carcinoma: Histopathological and clinical correlation

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 4, 1999, Pages 505-510

  Brasanac, D ^a   Muller C A ^b   Muller G A ^c   Hadzi Dzokic, J ^d   Markovic Lipkovski, J ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Clinical correlation; Histopathology; HLA class I antigens; Immunohistochemistry; Renal cell carcinoma

Indexed keywords

HLA ANTIGEN CLASS 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOLOGY; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL EXAMINATION; CORRELATION FUNCTION; FEMALE; GRANULAR CELL TUMOR; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL;

EID: 1642586783     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Morreta A., Bottino C., Vitale M. et al.: Receptors for HLA class-I molecules in human natural killer cells. Ann. Rev. Immunol. 14:619-48, 1996.
2. Lanier L.L.: NK cell receptors. Ann. Rev. Immunol. 16:359-93, 1998.
3. Pantel K., Schlimok G., Angstwurm M. et al.: Early metastasis of human solid tumours: expression of cell adhesion molecules. Ciba Found Symp. 189:157-173, 1995.
4. Rockett J.C., Darnton S.J., Cracker J., Matthews H.R., Morris A.G.: Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma. J. Clin. Pathol. 48:539-544, 1995.
5. Licht M.R., Novick A.C., Tubbs R.R., Klein E.A., Levin H.S., Streem S.B.: Renal oncocytoma: clinical and biological correlates. J. Urol. 150(5):1380-1383, 1993.
6. Jackson P.A., Green M.A., Marks C.G., King R.J.B., Hubbard R., Cook M.G.: Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas. Gut. 38:85-89, 1996.
7. Tomita Y., Nishiyama T., Fujiwara M., Sato S.: Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer. Br. J. Cancer. 62: 354-359, 1990.
8. Gastl G., Ebert T., Finstad C.L. et al.: Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma. J. Urol. 155: 361-367, 1996.
9. Buszello H., Ackermann R.: Expression of HLA class-I antigens on renal cell carcinoma and non-transformed renal tissue. Eur. Urol. 21: 70-74, 1992.
10. Buszello H., Ackerman R.: Immunohistochemical studies on the expression of HLA class I antigens in renal cell carcinoma: comparison of primary and metastatic tumor tissue. Eur. Urol. 25: 158-163, 1994.
11. Mattijssen V., Van Moorselaar J., De Mulder P.M., Schalkwijk L., Ruiter D.J.: Human leukocyte antigen expression in renal cell carcinoma lesions does not predict the response to interferon therapy. J. Immunother. 12: 64-69, 1992.
12. Heinemann D., Smith P.J.B., Symes M.O.: Expression of histocompatibility antigens and characterisation of mononuclear cell infiltrates in human renal cell carcinomas. Br. J. Cancer. 56: 433-437, 1987.
13. Sobin L.H., Wittekind (eds.).: TNM classification of malignant tumours (5th ed.), New York, John Wiley and Sons, 1997: 180-182.
14. Parham P., Barnstable C.J., Bodmer W.F.: Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C antigens. J. Immunol. 123:342-349, 1979.
15. Marković-Lipkovski J., Muller C.A., Risler T., Bohle A., Muller G.A.: Mononuclear leukocytes, expression of HLA class II antigens and intercellular adhesion molecule 1 in focal segmental glomerulosclerosis. Nephron. 59: 286-293, 1991.
16. Thoenes W., Storkel St., Rumpelt H.J.: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Path. Res. Pract. 181: 125-143, 1986.
17. Saito T., Kimura M., Kawasaki T., Shotaro S., Tomita Y.: MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host. Cancer Lett. 115:121-127, 1997. (Corrected and republished article originally printed in Cancer Lett. 109: 15-21, 1996).
18. Droz D., Zachar D., Charbit L., Gogusev J., Chrétien Y., Iris L.: Expression of human nephron differentiation molecules in renal cell carcinomas. Am. J. Pathol. 137: 895-905, 1990.
19. Luboldt H.J., Kubens B.S., Rubben H., Grosse-Wilde H.: Selective loss of human leukocyte antigens class I allele expression in advanced renal cell carcinoma. Cancer Res. 56: 826-830, 1996.
20. Störkel S., Steart P.V., Drenckhahn D., Thoenes W.: The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch. B Cell. Pathol. 56: 237-245, 1989.
21. Bernhard H., Karbach J., Wolfel T. et al.: Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones. Int. J. Cancer. 59: 837-842, 1994.
22. Schendel D.J., Gansbacher B., Oberneder R. et al.: Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. J. Immunol. 151: 4209-4220, 1993.
23. Brossart P., Stuhler G., Flad T. et al.: Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Cancer Res. 58: 732-36. 1998.
24. Jentzer P., Schendel D.: Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo. Cancer Res. 58: 3078-86. 1998.
25. Roosen J.U., Engel U., Jensen R.H., Kvist E., Schou G.: Renal cell carcinoma: prognostic factors. Br. J. Urol. 74: 160-164, 1994.
26. Usubütün A., Ayhan A., Uygur M.C., Özen H., Toklu C., Ruacan S.: Prognostic factors in renal cell carcinoma. J Exp. Clin. Cancer Res. 17:77-81. 1998.